Literature DB >> 11385711

The R71G BRCA1 is a founder Spanish mutation and leads to aberrant splicing of the transcript.

A Vega1, B Campos, B Bressac-De-Paillerets, P M Bond, N Janin, F S Douglas, M Domènech, M Baena, C Pericay, C Alonso, A Carracedo, M Baiget, O Diez.   

Abstract

In a BRCA1 screening in familial breast cancer carried out in different centres in Spain, France, and United Kingdom, a missense mutation 330A>G which results in a Arg to Gly change at codon 71 (R71G) was independently identified in 6 families, all of them with Spanish ancestors. This residue coincides with the -2 position of the exon 5 donor splice site. We further investigated the effect of this base substitution on the splicing of BRCA1 mRNA. The sequence analysis of the cDNA indicated that 22 bp of exon 5 were deleted, creating with the first bases of exon 6 a termination codon at position 64, which results in a truncated protein. The BRCA1 haplotype of the R71G carrier patients and Spanish controls was analysed by use of six microsatellites located within or near BRCA1. Our results are consistent with the possibility that these families shared a common ancestry with BRCA1 R71G being a founder mutation of Spanish origin. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11385711     DOI: 10.1002/humu.1136

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  48 in total

1.  Analysis of missense variation in human BRCA1 in the context of interspecific sequence variation.

Authors:  V Abkevich; A Zharkikh; A M Deffenbaugh; D Frank; Y Chen; D Shattuck; M H Skolnick; A Gutin; S V Tavtigian
Journal:  J Med Genet       Date:  2004-07       Impact factor: 6.318

2.  High proportion of novel mutations of BRCA1 and BRCA2 in breast/ovarian cancer patients from Castilla-León (central Spain).

Authors:  Mar Infante; Mercedes Durán; Eva Esteban-Cardeñosa; Cristina Miner; Eladio Velasco
Journal:  J Hum Genet       Date:  2006-06-07       Impact factor: 3.172

3.  A Multiplex Homology-Directed DNA Repair Assay Reveals the Impact of More Than 1,000 BRCA1 Missense Substitution Variants on Protein Function.

Authors:  Lea M Starita; Muhtadi M Islam; Tapahsama Banerjee; Aleksandra I Adamovich; Justin Gullingsrud; Stanley Fields; Jay Shendure; Jeffrey D Parvin
Journal:  Am J Hum Genet       Date:  2018-09-12       Impact factor: 11.025

4.  Heterogeneous prevalence of recurrent BRCA1 and BRCA2 mutations in Spain according to the geographical area: implications for genetic testing.

Authors:  Orland Diez; Sara Gutiérrez-Enríquez; Judith Balmaña
Journal:  Fam Cancer       Date:  2010-06       Impact factor: 2.375

5.  Massively Parallel Functional Analysis of BRCA1 RING Domain Variants.

Authors:  Lea M Starita; David L Young; Muhtadi Islam; Jacob O Kitzman; Justin Gullingsrud; Ronald J Hause; Douglas M Fowler; Jeffrey D Parvin; Jay Shendure; Stanley Fields
Journal:  Genetics       Date:  2015-03-30       Impact factor: 4.562

6.  Functional differences among BRCA1 missense mutations in the control of centrosome duplication.

Authors:  Z Kais; N Chiba; C Ishioka; J D Parvin
Journal:  Oncogene       Date:  2011-07-04       Impact factor: 9.867

7.  CHEK2 c.1100delC mutation among non-BRCA1/2 Spanish hereditary breast cancer families.

Authors:  L Fachal; M Santamariña; A Blanco; A Carracedo; A Vega
Journal:  Clin Transl Oncol       Date:  2012-11-13       Impact factor: 3.405

8.  Comparison of mRNA splicing assay protocols across multiple laboratories: recommendations for best practice in standardized clinical testing.

Authors:  Phillip J Whiley; Miguel de la Hoya; Mads Thomassen; Alexandra Becker; Rita Brandão; Inge Sokilde Pedersen; Marco Montagna; Mireia Menéndez; Francisco Quiles; Sara Gutiérrez-Enríquez; Kim De Leeneer; Anna Tenés; Gemma Montalban; Demis Tserpelis; Toshio Yoshimatsu; Carole Tirapo; Michela Raponi; Trinidad Caldes; Ana Blanco; Marta Santamariña; Lucia Guidugli; Gorka Ruiz de Garibay; Ming Wong; Mariella Tancredi; Laura Fachal; Yuan Chun Ding; Torben Kruse; Vanessa Lattimore; Ava Kwong; Tsun Leung Chan; Mara Colombo; Giovanni De Vecchi; Maria Caligo; Diana Baralle; Conxi Lázaro; Fergus Couch; Paolo Radice; Melissa C Southey; Susan Neuhausen; Claude Houdayer; Jim Fackenthal; Thomas Van Overeem Hansen; Ana Vega; Orland Diez; Rien Blok; Kathleen Claes; Barbara Wappenschmidt; Logan Walker; Amanda B Spurdle; Melissa A Brown
Journal:  Clin Chem       Date:  2013-11-08       Impact factor: 8.327

9.  Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Cuba.

Authors:  Rolando Comacho Rodriguez; Antonio Alejandro Esperon; Ramon Ropero; Maria Caridad Rubio; Ronald Rodriguez; Rosa M Ortiz; Juan J Lence Anta; Mario de los Rios; Deyanira Carnesolta; Maria C del Olivera; Somalia Stiu Vansam; Robert Royer; Mohammad R Akbari; Talia Donenberg; Steven A Narod
Journal:  Fam Cancer       Date:  2008-02-20       Impact factor: 2.375

10.  Evidence for an ancient BRCA1 mutation in breast cancer patients of Yoruban ancestry.

Authors:  Bifeng Zhang; James D Fackenthal; Qun Niu; Dezheng Huo; Walmy E Sveen; Tiffani DeMarco; Clement A Adebamowo; Temidayo Ogundiran; Olufunmilayo I Olopade
Journal:  Fam Cancer       Date:  2008-08-05       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.